Dr. Alan Wein sums up progress on the latest treatment modalities for prostate cancer. Learn more about Dr. Wein.
Watch Now »

Dr. Bruce Malkowicz talks about advanced disease and aggressive treatment for bladder cancer. Learn more about Dr. Malkowicz.
Watch Now »

Dr. Corey Langer of Penn Medicine reveals promising news behind the latest trials and therapies for a subset of lung cancer patients. Learn more about Dr. Langer.
Watch Now »

Dr. Lynn Schuchter discusses novel therapies and clinical trials for patients with advanced melanoma and what these new developments could mean in treating other cancers. Learn more about Dr. Schuchter.
Watch Now »

Penn Medicine’s Dr. Kathryn Schmitz discusses the departure from the simple rest and recovery prescription many cancer patients receive after treatment. New evidence suggests cancer patients do better when they avoid inactivity. Learn more about Dr. Schmitz.
Watch Now »

6-Minute Cancer Survivorship Care Plans Now Online

With 12 million cancer survivors across the United States, some of the breaking news from the 2009 American Society of Clinical Oncology (ASCO) meeting in Orlando, Florida, concerned the development of survivor care plans. These are designed to help cancer survivors and their doctors be vigilant about the late side effects from past cancer treatments, early signs of second cancers, and on-going psychological and financial needs. Traditionally, cancer doctors and patients focused on beating the cancer. Now, there is an additional focus on enhancing the quality of long-term survivorship.

Listen to James Metz, MD, speak about 6-Minute Cancer Survivorship Care Plans Now Online »

Chronic Myelogenous Leukemia

New developments in research for cancer is always highly anticipated by patients, and this year’s 50th Annual Meeting of the American Society of Hematology (ASH) did not disappoint, particularly for patients affected by chronic myelogenous leukemia (CML). CML is quite often referred to as the “monster mutation” and is often resistant to numerous therapies. Unraveling the mystery of these mutations and understanding the biology of patients with these mutations is one of the focal points of this discussion. As Patient Power host Andrew Schorr broadcasts live from the ASH meeting, Dr. Alison Loren joins to shed light on breakthroughs in CML. Dr. Loren is a hematologist/oncologist in the Division of Hematology-Oncology at the Hospital of the University of Pennsylvania.

Listen to Alison Loren, MD, MS, speak about Chronic Myelogenous Leukemia »

Multiple Myeloma Treatment

Multiple Myeloma, cancer of the plasma cell, can be a devastating diagnosis. While not curable, the disease is treatable. Joining Patient Power host, Andrew Schorr, is Dr. Dan Vogl from the University of Pennsylvania, broadcasting live from the 50th annual meeting of the American Society of Hematology (ASH) in San Francisco. This meeting joins renowned experts in blood cancers and blood diseases from around the world to collaborate on the latest research.

Listen to Dan Vogl, MD, speak about Multiple Myeloma Treatment »

Lymphoma Research

Each year the American Society of Hematology (ASH) brings together experts on blood-related cancers and other conditions. On this episode of Patient Power, host Andrew Schorr broadcasts from the 50th annual ASH meeting in San Francisco. Andrew is joined by Dr. Stephen Schuster, director the lymphoma program at the University of Pennsylvania in Philadelphia. Dr. Schuster shares information about the newest lymphoma treatments and research.

Listen to Stephen Schuster, MD, speak about Lymphoma Research »